ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Selexis SA Appoints Hoffmann-Hecht CBO
June 03, 2021Dr. Hoffmann-Hecht will serve on the executive leadership team and will report to Selexis CEO Dirk Lange. -
Selexis SA and Turgut Pharmaceuticals Expand Biosimilar Development Relationship by Signing Two Commercial License Agreements
February 28, 2019Selexis SA and Turgut Pharmaceuticals (Turgut Ilaclari A.S.) announced today that they have signed two commercial license agreements (CLAs) through which Turgut will leverage Selexis’ SUREtechnology Platform™ and ... -
Selexis SA and Hoba Therapeutics Team Up to Advance Hoba’s Investigational Neuropathic Pain Treatment into the Clinic
September 28, 2018Selexis SA and Hoba Therapeutics announced today that they have entered into an agreement to advance the development of Hoba’s clinical candidate HB-086 (rhMeteorin) for the treatment of peripheral neuropathic pain.
Pharma Sources Insight January 2025
